13th Aug 2019 12:30
(Alliance News) - Hikma Pharmaceuticals PLC said Tuesday its finance chief and mergers & acquisition head sold shares in the FTSE 250-listed drugmaker worth GBP2.5 million in separate transaction on Monday.
Chief Financial Officer Khalid Nabilsi sold 45,000 shares at 1,968 pence each, worth GBP885,600.
Corporate Development & M&A Executive Vice President Bassam Kanaan disposed of 84,500 shares at the same price, worth GBP1.7 million.
Shares in Hikma were 0.2% lower at 1,981.50p in London on Tuesday.
Following the transactions, the holdings of Nabilsi or Kanaan - if any - were not disclosed.
Related Shares:
Hikma Pharmaceuticals